The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke

NCT00868283 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1071

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Cerebrolysin
DRUG: 0.9% Saline Solution

Sponsor

Ever Neuro Pharma GmbH

Collaborators

[object Object]
[object Object]